Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19)

BACKGROUND: No standard therapy is currently recommended for Corona-virus-19 disease (COVID-19). Autopsy studies showed high prevalence of platelet-fibrin rich micro-thrombi in several organs. Aim of the study was to evaluate safety and efficacy of antiplatelet therapy (APT) in COVID-19 hospitalized...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, F, Vitale, E, Nunez Gil, I, Guerra, F, El-Battrawy, I, Brunetti, N D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Abstract Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767628/
http://dx.doi.org/10.1093/eurheartj/ehab724.3002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767628/
http://dx.doi.org/10.1093/eurheartj/ehab724.3002

Ejemplares similares